Details about the neuroanatomical projections from RSPv to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|
| 91027 |
Retrosplenial area ventral part | Ectorhinal area |
moderate | biotinylated dextran amine (BDA) | At more caudal levels (Fig. 3C), labeled terminals were distributed bilaterally in layers V and VI of the entorhinal and perirhinal areas. Collator note: See Fig. 3C, Swanson Atlas Level 45. | Shibata H, 1994 |
|---|
| 91034 |
Retrosplenial area ventral part | Ectorhinal area |
light | biotinylated dextran amine (BDA) | Collator note:few labeled terminals in the caudal ENTm. See Fig. 4C, Swanson Atlas Level 45. | Shibata H, 1994 |
|---|
|
General description technique/protocol: injection into the mid-rostrocaudal part of the RSG (Fig. 3A) […]. Collator note: the injection may have partially covered RSPv-b/c. |
Further details associated to record number 91027:
| Position of injection: caudal |
| Topological position of injection: is contained |
| Extension of injection outside: none |
| The injection was performed in: right hemisphere |
| | Position of terminal field: caudal |
| Topological position of terminal field: is contained |
| Extension of terminal field outside: none |
| The terminal field was found: ipsilateral |
| |
